Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hemmersbach

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Drug Testing and Analysis|December 5, 2019
The Probenecid-story - A success in the fight against doping through out-of-competition testingPeter Hemmersbach
Journal of Mass Spectrometry : JMS|June 24, 2008
History of mass spectrometry at the Olympic GamesPeter Hemmersbach
Drug Testing and Analysis|March 10, 2011
Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parametersYvette Dehnes, Peter Hemmersbach
Handbook of Experimental Pharmacology|December 19, 2009
Nandrolone: a multi-faceted doping agentPeter Hemmersbach, Joachim Grosse
Drug Testing and Analysis|November 13, 2014
Carbon isotope ratios of nandrolone, boldenone, and testosterone preparations seized in Norway compared to those of endogenously produced steroids in a Nordic reference populationIngunn Hullstein, Carlos Sagredo, Peter Hemmersbach
Medizinische Klinik (Munich, Germany : 1983)|December 30, 2009
[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]Mario Thevis, Peter Hemmersbach, Hans Geyer, et al.
Drug Testing and Analysis|January 5, 2011
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparationJohn Henninge, Milaim Pepaj, Ingunn Hullstein, et al.
Medicine and Science in Sports and Exercise|April 6, 2004
Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping controlGro Nissen-Lie, Kåre Birkeland, Peter Hemmersbach, et al.
Drug Testing and Analysis|November 26, 2014
MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samplesYvette Dehnes, Linda Myrvold, Helene Ström, et al.
Drug Testing and Analysis|March 19, 2016
Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects in relation to doping analysisNanna Krogh, Vibeke Backer, Sebastian Rzeppa, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Drug Testing and Analysis|December 5, 2019
The Probenecid-story - A success in the fight against doping through out-of-competition testingPeter Hemmersbach
Journal of Mass Spectrometry : JMS|June 24, 2008
History of mass spectrometry at the Olympic GamesPeter Hemmersbach
Drug Testing and Analysis|March 10, 2011
Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parametersYvette Dehnes, Peter Hemmersbach
Handbook of Experimental Pharmacology|December 19, 2009
Nandrolone: a multi-faceted doping agentPeter Hemmersbach, Joachim Grosse
Drug Testing and Analysis|November 13, 2014
Carbon isotope ratios of nandrolone, boldenone, and testosterone preparations seized in Norway compared to those of endogenously produced steroids in a Nordic reference populationIngunn Hullstein, Carlos Sagredo, Peter Hemmersbach
Medizinische Klinik (Munich, Germany : 1983)|December 30, 2009
[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]Mario Thevis, Peter Hemmersbach, Hans Geyer, et al.
Drug Testing and Analysis|January 5, 2011
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparationJohn Henninge, Milaim Pepaj, Ingunn Hullstein, et al.
Medicine and Science in Sports and Exercise|April 6, 2004
Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping controlGro Nissen-Lie, Kåre Birkeland, Peter Hemmersbach, et al.
Drug Testing and Analysis|November 26, 2014
MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samplesYvette Dehnes, Linda Myrvold, Helene Ström, et al.
Drug Testing and Analysis|March 19, 2016
Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects in relation to doping analysisNanna Krogh, Vibeke Backer, Sebastian Rzeppa, et al.
Pageof 3